Showing results (611-620 of 712) with videos related to

Sort By:
Pageof 72
Expert Opinion on Emerging Drugs|October 30, 2025
Mezigdomide for multiple myeloma: a focus on phase 2 trial dataClifton C Mo, Yuxin Liu, Omar Nadeem, et al.
British Journal of Cancer|July 23, 2013
A randomised trial of weekend and evening breast screening appointmentsJ Offman, M Wilson, M Lamont, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|October 30, 2016
Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamideLuke Pett, Konstantinos Kiakos, Vijay Satam, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 17, 2010
DNA recognition: design, synthesis and biophysical characteristics of pyrrole(H) based polyamidesSameer Chavda, Keith Mulder, Toni Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2011
Phase I pharmacokinetic and pharmacodynamic study of SJG-136, a novel DNA sequence selective minor groove cross-linking agent, in advanced solid tumorsIgor Puzanov, Wooin Lee, Alice P Chen, et al.
Expert Review of Hematology|July 26, 2024
Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomideYuxin Liu, Clifton C Mo, Monique A Hartley-Brown, et al.
Scientific Reports|February 9, 2022
Machine learning outperforms clinical experts in classification of hip fracturesE A Murphy, B Ehrhardt, C L Gregson, et al.
Pageof 72